Maduropeptin, a complexof newmacromolecular antitumor antibiotics, is a metabolite of Actinomadura madurae H710-49. The active components maduropeptins A1? A2 and B are acidic chromopeptides with MWof around 22,500 and composed of 14 types of amino acids and an unstable chromophore. The antibiotics are active in vitro against Gram-positive bacteria and highly cytotoxic to tumor cells. They produced significant prolongation of survival time of mice implanted with P388 leukemia and B16 melanoma. 403 In the course of screening for novel metabolites active against murine P388 leukemia in mice, we found a complexof newmacromolecularantibiotics designated maduropeptin. The producing culture H710-49, isolated from a soil sample collected in Germany, was identified as Actinomadura madurae (ATCC39144). Maduropeptin is an acidic macromolecular substance from its extraction behavior; the active principle was recovered from the fermentation broth by use of a basic ion exchange resin. HPLC analysis indicated that the crude solid contained at least four active components (maduropeptins Al9 A2, B and D) and an inactive component (maduropeptin C) having similar physico-chemical properties. Upon UVirradiation in a cold room, components B and D were decomposed yielding a complex of components A1? A2 and C which were isolated as single entities by chromatography. The bioactive maduropeptin components showed MW'saround 22,500 and characteristic UVabsorption maximaat 210, 286 and 308 nm. They exhibited potent inhibitory activity against Gram-positive bacteria and tumor cells and strong in vivo antitumor effect against P388 leukemia and B16 melanomaimplanted in mice. In this paper, we report the producing organism, production, isolation, chemical properties and biological activities of maduropeptin.
In the course of screening for novel metabolites active against murine P388 leukemia in mice, we found a complexof newmacromolecularantibiotics designated maduropeptin. The producing culture H710-49, isolated from a soil sample collected in Germany, was identified as Actinomadura madurae (ATCC39144). Maduropeptin is an acidic macromolecular substance from its extraction behavior; the active principle was recovered from the fermentation broth by use of a basic ion exchange resin. HPLC analysis indicated that the crude solid contained at least four active components (maduropeptins Al9 A2, B and D) and an inactive component (maduropeptin C) having similar physico-chemical properties. Upon UVirradiation in a cold room, components B and D were decomposed yielding a complex of components A1? A2 and C which were isolated as single entities by chromatography. The bioactive maduropeptin components showed MW'saround 22,500 and characteristic UVabsorption maximaat 210, 286 and 308 nm. They exhibited potent inhibitory activity against Gram-positive bacteria and tumor cells and strong in vivo antitumor effect against P388 leukemia and B16 melanomaimplanted in mice. In this paper, we report the producing organism, production, isolation, chemical properties and biological activities of maduropeptin.
Producing Organism Poor to moderate Colorless to deep yellow (85) Poor; pinkish white (9) Tables 1 and 2, respectively. Purified cell-wall of strain H710-49 contains m&so-diaminopimelic acid but lacks glycine. The whole cell hydrolysate shows the presence of madurose (3-0-methyl-D-galactose), glucose, ribose and a small amount of mannose. The cell-wall composition and whole cell sugar components of strain H7 10-49 indicate that the strain belongs to cell-wall type IIIB. The phospholipids contain phosphatidylinositol and phosphatidylglycerol, but not nitrogenous phospholipids, hence belong to type P-I. The menaquinone contains 68% of MK-9 (H6) and 20% of MK-9 (H8). The above-described characteristics of strain H710-49 resemble those of membersof the genus Actinomadura Lechevalier et Lechevalier 19701) . According to the taxonomic description of knownActinomadura species2~5), strain H710-49 is similar to Actinomadura cremea, Actinomadura madurae and Actinomadura verrucosospora. As shownin Table 3 , further comparisons of the strain to the three species revealed that the strain is partially different from them, but is most similar to A. madurae. The strain is differentiated from A. madurae only in the absence of melanin formation and the lack of sucrose utilization.
Antibiotic Production An agar slant with well-established growth of A. madurae H710-49 (ATCC39144) was used to inoculate seed medium (100ml in a 500-ml Erlenmeyer flask) containing mannitol 1%, peptone 2% and yeast extract 1%; the pH was adjusted to 7.2 before autoclaving. The seed culture was incubated at 32°C for 72 hours on a rotary shaker (250rpm). Five ml of the mature culture was transferred to the second seed medium(100ml) with the same composition as the first seed medium, and the seed was cultivated under the same conditions. Five ml of the inoculum growth thus prepared was employedto start fermentation in 500-ml Erlenmeyer flasks containing 100ml of fermentation mediumcomposed of mannitol 2.5%, glucose 0.5%, soybean meal 1%, peptone 0.5%, meat extract 1%, CaCO3 0.3% and sodium chloride 0.2%. Fermentation was carried out at 28°C on a rotary shaker at 250rpmagitation. The antibiotic production was monitored by the paper-disc agar diffusion assay using Bacillus subtilis M45(rec~mutant)6) as the test organism. The antibiotic activity in the culture broth gradually increased and reached a maximum of 300/ig/ml after 6~7 days.
Fermentation was also carried out in a tank fermenter (200 liters). The second seed culture (5,000 ml) described above was inoculated to the fermenter containing 120 liters of the production medium composed of corn starch 5.0%, soybean meal 1.0%, Pharmamedia 1.0%, yeast extract 1.0% and CaCO3 1.0%, the pH was adjusted to 7.0 after sterilization.
The tank fermenter was operated at 28°C at 250 rpm agitation and an aeration rate of 120 liters/minute. The pH of the culture broth gradually rose with the progress of fermentation and reached 7.8 after 72 hours when a peak antibiotic potency of 500 /xg/ml was obtained. monitored by HPLCand appropriate fractions were combined and dialyzed against deionized water to obtain a solution containing nearly pure maduropeptin A1 (14mgweight). The semi-pure maduropeptin B solution (70mg equivalent) was similarly purified to yield a solution containing 27mg of nearly pure maduropeptin B.
Purification of Photo-degradation Products
The natural maduropeptin components A1? B, C and D, were found to be reasonably stable at 5°C in the dark but components B and D were shown by HPLCto be readily decomposed by light to a mixture ofmaduropeptins Ax and C (Fig. 3) . Whenthe solution was allowed to stand at room temperature under light, maduropeptin Ax was also decomposed giving only bioinactive maduropeptin C. Purification and characterization of the major products was attempted, utilizing photo-degradation to simplify the problem.
A solution of components Al5 B, C and D (ratio, 29 : 23 : 35 : 21) was gently stirred under a fluorescent (Fig. 4) .
Physico-chemical Properties
The four components, maduropeptins A1? A2, B and C were isolated as described above but maduropeptin D has not been obtained as a single entity. Maduropeptin C is very stable and At and A2 are fairly stable to isolation work-up. Maduropeptin B is, however, very unstable upon solidification and thus only limited data on this component were obtained. They are distinguished from each other by HPLC as shown in Fig. 3 . The four components are readily soluble in water but are insoluble and decomposein organic solvents resulting in complete loss of the activity. They were positive with Folin-Lowry, xanthoprotein, biuret and ninhydrin reagents but negative to Sakaguchi and anthrone reagents. Maduropeptins Al and A2 exhibited UVabsorption maxima at 210, ca. 280 and 308 nmwhile maduropeptin C lacked the maximumat 308 nm. Someof the physico-chemical data are shown in Table 4 . The acidic nature of the four maduropeptin components was indicated by their isoelectric points. Maduropeptins Al9 A2 and B are stable in neutral conditions at 5°C but gradually decompose at roomtemperature. They are unstable in acidic or alkaline solution or upon UVirradiation. 
MW Determination
The MWof maduropeptin C was estimated by gel filtration using a Sephadex G-75 column (22 x 685 mm)and 1/15 m phosphate buffer pH 7.0 with a flow rate of 30 ml/hour. The calibration standard kit (Pharmacia Fine Chem.) comprised of blue dextran (MW2,000,000), bovine serum albumin (MW 67,000), ovalbumin (MW43,000), chymotrypsinogen (MW25,000) and ribonuclease A (MW13,700) was chromatographed simultaneously. Maduropeptin C was eluted just after chymotrypsinogen as monitored by HPLCand its MWwas calculated to be 22,500. Upon HPLCco-chromatography with the standard kit (Asahipak GS-320, 7.6 x 500mm, Asahi Chemical Industry Co. and 0.1 m phosphate buffer, pH 7.0, containing 0.3 msodium chloride), maduropeptin C was eluted before chymotrypsinogen indicating a molecular weight of 27,000.
Amino Acid Analysis Maduropeptins A1? B and C were hydrolyzed with 6n HC1 at 1 10°C for 22 hours. Part of the solution was oxidized with performic acid at 1 10°C for 20 hours for determination of cystine and tryptophan. After concentration to dryness in vacuo, the residue was subjected to amino acid analysis by a Waters Pico tag amino acid analyzer (Waters type ALC/GPC606) with the results described in Table 5 . Noteworthy is that all maduropeptin components do not contain basic amino acids, which distinguish them from the knownmacromolecular chromoprotein antibiotics.
Non-protein Chromophore
Maduropeptins B and D are highly sensitive to UV light yielding the bioinactive apoprotein maduropeptin C. Maduropeptins Al and A2 are rather refractory to UV, but upon treatment with acidic methanol, they afforded a lipophilic substance with antimicrobial and cytotoxic activity, along with maduropeptin C. Preliminary characterization indicated that the bioactive degradation product has UV absorption considerably different from that of the original antibiotics and does not show synergistic antimicrobial effect with maduropeptin C7). The results suggested that the bioactive degradation product wasnot a true non-protein chromophorebut rather an artifact. Antimicrobial Activity The antimicrobial activity, measured as MIC, of maduropeptins Al9 A2, B and C was assessed using the agar dilution assay. Nutrient broth was used for Gram-positive and Gram-negative bacteria and Sabouraud dextrose broth for fungi. The inoculum size was adjusted to 105~106 cfu/ml for bacteria and 106 cfu/ml for fungi. Incubation was carried out at 28°C for 18 hours and neocarzinostatin (NCS) was used as a reference compound. The results are shownin Table 6 . Maduropeptins A1? A2 and B exhibited significant inhibitory activity against Gram-positive bacteria with MICsbeing 2~15 times greater than those of NCS. They were inactive against Gram-negative bacteria. Maduropeptin C, the apoprotein of the components Al, A2and B, did not show in vitro activity.
Antitumor Activity
Maduropeptin components were tested for in vitro cytotoxicity against murine and humantumor cells and for in vivo antitumor activity in mice. NCSwas used as a reference compoundfor both in vitro and in vivo experiments.
In Vitro Cytotoxicity
Murine melanomaB16-F10cells were grown in Eagle's minimumessential mediumsupplemented with fetal calf serum (FCS, 10%) and kanamycin (60 /zg/ml), and human colon carcinoma HCT-1 16 cells in McCoy's 5A medium supplemented with FCS (10%), benzylpenicillin (lOOu/ml), and streptomycin (lOO jug/ml). Exponentially growing B16-F10 and HCT-1 16 cells were harvested, counted and suspended in the culture medium at 3 x 104 and 6 x 104 cells/ml, respectively. After planting 180^1 of cell suspension into wells of a 96-well microtiter plate with test samples (20^1), the plates were incubated at 37°C in a humidified atmosphere of 5% CO2and 95%air for 72 hours. The cytotoxicity was colorimetrically determined at 540 nm after staining the viable cells with neutral red solution. Maduropeptin components Al9 A2 and B showed potent cytotoxicity with IC50 values ranging from 0.007 to 0. 16 jUg/ml against both more potent activity than NCS. Maduropeptin C did not show cytotoxicity at 100 jUg/ml against either cell line (Table 7) .
In Vivo Antitumor Activity
The in vivo antitumor activity of maduropeptin Table 9 . Antitumor activity of maduropeptin Ax against P388 (ip) in male BDFi mice. components was examined against P388 lymphocytic leukemia and melanoma B16. P388 cells (106 cells per mouse) were inoculated intraperitoneally into male BDFi or female CDFXmice. Graded doses of the test materials were administered intraperitoneally to groups of4 female CDFj mice on days 1 to 3 (Q1D x 3) or to groups of 6 male BDFj mice on days 1 to 9 (Q1D x 9) after tumor implantation (day 0). Death or survival of the treated and non-treated animals was recorded daily during the observation period of 45 days and the median survival time (MST) was calculated for the test.(T) and control (C) groups. A T/C value of^125%is considered a significant antitumor effect. As shown in Table 8 , maduropeptin components Al5 A2 and B gave highly potent antitumor activity with maximumT/C values of 165%, 155% and 235% (QlD x 3 treatment), respectively, against P388 leukemia. When compared with NCS in the QlD x9 treatment against P388 leukemia, maduropeptin At was approximately 10-fold more potent than NCSin terms of minimumeffective dose (Table 9 ). Anti-B 1 6 melanomaactivity ofmaduropeptin Ai was determined VOL.44 NO. 4 THE JOURNAL OF ANTIBIOTICS 413 in the mouse subrenal capsule (SRC) assay8). A minced fragment of the melanoma was implanted beneath the renal capsule of male BDFimice and each initial graft size wasmeasured with an ocular micrometer scale (day 0). The animals were randomized in groups of 4 and treated with graded doses of the test materials on days 1 to 5 (Q1D x 5). On day 6, the kidney was excised and the final graft size was determined. Antitumor activity was expressd as %inhibition of tumor growth and an inhibition value of^50%is considered significant antitumor activity. As shown in Table 10 , maduropeptin Ax gave dose-related inhibition of tumor growth and was approximately 50-fold more active than NCSin terms of minimum effective dose.
Acute Toxicity The acute toxicity was determined by intraperitoneal administration of graded doses of the materials to groups of 5 normal male ddYmice. The LD50was calculated 10 days after administration according to the method of Van der Waerden9). Maduropeptin At (LD50 0.067 mg/kg) was approximately 50-fold more toxic than NCS(LD50 3.1 mg/kg) tested as a reference.
Discussion
Five components of antitumor antibiotic maduropeptin have been isolated from the culture filtrate of A. madurae strain No. H710-49. They are acidic polypeptides and the bioactive components, maduropeptins Al5 A2, B and D carry a chromophore unit.
Many chromoprotein antibiotics including neocarzinostatin1 0), auromomycin1 1*, macromomycin12), actinoxanthin13), sporamycin14), largomycin1 5) and C-102716) have been identified as effective antitumor agents and, amongthem, neocarzinostatin is in clinical use. Maduropeptin appears to be a new addition to this family from its physico-chemical and biological profile, but it is distinctly different from the preceding antibiotics in not containing basic amino acids. As mentioned previously, attempts to isolate a true non-protein chromophoreof maduropeptinwere unsuccessful. Isolation and characterization of the chromophore are continuing and will be reported later.
